Debaters Argue Merits of Surgery in Malignant Meso in Light of MARS2 Data

… of surgery in the treatment of malignant mesothelioma began circulating. And after a debate at the 2024 Targeted … mesothelioma is maximal cytoreduction to remove all visible tumor, but an R0 resection is not possible. Surgery alone is …

Phase II Trial Evaluates Amivantamab Plus Lazertinib in EGFR-Mutant Lung Cancers With New or Progressing Brain Metastases or Leptomeningeal Disease

… the formal response criteria. However, when we examined CSF circulating tumor cells (CTCs), 67% of patients demonstrated a reduction in tumor burden. This discordance suggests that conventional …